Please join Winchester’s Managing Director, Michael O. Regentz, CSI (IIE), CeBSA (IBM), in a timely discussion that reveals new information about the impact of Adaptive Clinical Trials on eClinical systems.. It has become self-evident that employing Adaptive Clinical Trials will have a dramatic, positive impact on a company’s clinical development program. There are significant promises that emanate from this new practice and the new technology of Adaptive Clinical Trials. The promises can include shortened drug development cycles, improved safety profiles, and reductions in the cost of a clinical trial. For Adaptive Trials to be truly successful the clinical trial management system (CTMS) that companies use to manage trials must be designed to accommodate the drive of this new technology. The objective of this one-hour Webinar presented by IBM and Winchester is to highlight how the CTMS also must adapt and work well together with the other eClinical systems that the companies are using to support the needs of Adaptive Clinical Trials. Date: Thursday, May 28, 2009 Time: 12 pm ET / 9 am PT Duration: 60 Minutes